Daily as of 2 Nov 16:00 ET
- Price
- below both $9.11 vs 50 $15.15 / 200 $23.01
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 17 Sep 2026 · projected 28 bars out
STRO | Sutro BiopharmaNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$9.11
+$0.01 (+0.11%)
Sutro Biopharma (STRO) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.
The 50 SMA has sat below the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $9.10 vs 50 $20.66 / 200 $29.74
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 13:30 ET
- Price
- below both $9.62 vs 50 $11.99 / 200 $20.64
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 22 Jul 2026 · projected 29 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 17 Sep 2026 | 💀Death steep | daily | 28 bars out | Not tested |
| 22 Jul 2026 | 💀Death | 4-hour | 29 bars out | Not tested |
| 26 Dec 2025 | 🟨Golden | 4-hour | 12 bars out | Not tested |
| 5 Dec 2025 | 💀Death | 4-hour | 24 bars out | 6 bar cross test |
| 28 Nov 2025 | 🟨Golden flat | daily | 9 bars out | 4 bar cross test |
About STRO
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$4M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorHealthcare
Cap bandsmall